Posted Bill Couzens, Founder

Former Vols guard Lofton underwent cancer treatment

From wire reports
KNOXVILLE, Tenn. — Former Tennessee guard Chris Lofton underwent treatment for testicular cancer after a failed drug test at the 2007 NCAA tournament revealed he potentially had a tumor.

“I would like to thank everyone for respecting my privacy during the past year, and I hope that they continue to do so,” Lofton said in a statement released by the school Thursday evening. “This has been a very difficult time for me and my family but it has brought us closer together. I have been very blessed that we were able to catch everything early so that now I am OK.”

Several school officials declined to comment further about Lofton’s condition, citing HIPPA medical privacy laws. Neither Lofton nor his parents returned messages from The Associated Press seeking further comment.

The Knoxville News Sentinel reported Thursday that Lofton said he had four weeks of adiation treatment for testicular cancer last March. Lofton said he has made a full recovery but the treatment made it hard for him to train and that he didn’t feel he was at full strength until mid-season.

According to an story, Lofton was randomly picked during the 2007 NCAA tournament for a drug test, which revealed high levels of hCG, a hormone that serves as an indicator of pregnancy in women, steroid use or cancer.

Lofton’s 431 three-pointers are a Southeastern Conference record and rank third in NCAA history. He was The Associated Press’ SEC player of the year as a junior and a second-team All-America.

He was a preseason All-America going into his senior season, but fans and reporters began raising questions when he started the season in a shooting slump.

His shooting improved during the second half of the season, and he still led Tennessee in scoring at 15.5 points per game, though it was a drop from his 20.8 as a junior. He was a third-team All-America.